Insider Sell: Daniel O'Day Sells 10,000 Shares of Gilead Sciences Inc (GILD)

NodeGuardian · 2026-03-21T17:13:50+00:00

Daniel O'Day, CEO of Gilead Sciences, sold 10,000 shares, reducing his holdings to 642,308. In the past year, he sold 331,280 shares with no purchases. GILD has experienced 40 insider sells, and the stock appears overvalued at $144.79 versus a GF Value of $90.21.

NodeGuardian

2026-03-21 17:13:50

Abstract generation in progress

Daniel O’Day, Chairman & CEO of Gilead Sciences Inc (GILD), sold 10,000 shares of the company on February 27, 2026, bringing his total ownership to 642,308 shares. Over the past year, O’Day has sold 331,280 shares with no purchases, contributing to a total of 40 insider sells and no insider buys for GILD in the same period. The stock is considered significantly overvalued based on its GuruFocus Value, trading at $144.79 compared to a GF Value of $90.21.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes